Exact Mass: 363.21220760000006

Exact Mass Matches: 363.21220760000006

Found 247 metabolites which its exact mass value is equals to given mass value 363.21220760000006, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   

Dioncophylline C

Dioncophylline C

C23H25NO3 (363.18343400000003)


An isoquinoline alkaloid that is the biaryl resulting from substitution of the hydrogen at the 5-position of (1R,3R)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol by a 5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl group. It is a naphthylisoquinoline alkaloid isolated from the roots and stem barks of Triphyophyllum peltatum and exhibits antimalarial activity.

   

MLS000736682

1H-5alpha-Androst-2-eno[3,2-b]indol-17beta-ol

C25H33NO (363.25620080000004)


   

6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid

6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-3-carboxylic acid

C24H29NO2 (363.2198174)


   
   

Cetrimonium Bromide

Hexadecyl trimethyl ammonium bromide

C19H42N. Br (363.25004320000005)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent C254 - Anti-Infective Agent > C52588 - Antibacterial Agent D000890 - Anti-Infective Agents Same as: D03454

   

Murrayanol

1-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-7-methoxy-6-methyl-9H-carbazol-2-ol

C24H29NO2 (363.2198174)


Murrayanol is found in herbs and spices. Murrayanol is an alkaloid from seeds of Murraya koenigii (curry leaf tree). Alkaloid from seeds of Murraya koenigii (curry leaf tree). Murrayanol is found in herbs and spices.

   

Talinolol

N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N-cyclohexylcarbamimidic acid

C20H33N3O3 (363.2521788)


Talinolol belongs to the family of Alkyl Aryl Ethers. These are organic compounds containing the alkyl aryl ether functional group with formula R-O-R , where R is an alkyl group and R is an aryl group. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

N-Palmitoyltaurine

2-[(1-Oxohexadecyl)amino]ethanesulfonic acid

C18H37NO4S (363.24431620000007)


N-Palmitoyltaurine, also known as N-hexadecanoyltaurine, belongs to the class of organic compounds known as N-acyl amines. N-Acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Thus, N-palmitoyltaurine is considered to be a fatty amide lipid molecule. N-Palmitoyltaurine is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Specifically, N-palmitoyltaurine belongs to the N-acyl taurines (NATs) fatty acid amide class. NATs with chains ranging in length from C16 to C24 have been identified in mice brain, liver, and kidney tissues. NATs were found to be regulated by the integral membrane enzyme fatty acid amide hydrolase (FAAH) and activated calcium channels from the transient receptor potential (TRP) family such as TRPV1 and TRPV4 (PMID: 16866345).

   

N-Lauroyl Tyrosine

2-[(1-Hydroxydodecylidene)amino]-3-(4-hydroxyphenyl)propanoate

C21H33NO4 (363.2409458000001)


N-lauroyl tyrosine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Tyrosine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Tyrosine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Tyrosine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

2-(1-(5-Fluoropentyl)-1H-indazole-3-ylcarbonylamino)-3-methylbutanoic acid methyl ester

2-(1-(5-Fluoropentyl)-1H-indazole-3-ylcarbonylamino)-3-methylbutanoic acid methyl ester

C19H26FN3O3 (363.1958098)


   

6-Hydroxyindoramin

N-{1-[2-(6-hydroxy-1H-indol-3-yl)ethyl]piperidin-4-yl}benzamide

C22H25N3O2 (363.194667)


   

Bucindolol

2-(2-hydroxy-3-{[1-(1H-indol-3-yl)-2-methylpropan-2-yl]amino}propoxy)benzonitrile

C22H25N3O2 (363.194667)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Bucindolol is a β1-adrenergic receptor blocker, with intrinsic sympathomimetic activity, used in the research of heart failure[1].

   

Dioncophylline C

5-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol

C23H25NO3 (363.18343400000003)


   

6-[1-(3,5,5,8,8-Pentamethyl-6,7-dihydronaphthalen-2-yl)cyclopropyl]pyridine-2-carboxylic acid

6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-2-carboxylic acid

C24H29NO2 (363.2198174)


   

Libenzapril

6-amino-2-{[1-(carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino}hexanoic acid

C18H25N3O5 (363.179412)


   

Thiencynonate

3-Methyl-3-azabicyclo[3.3.1]nonan-9-yl 2-cyclopentyl-2-hydroxy-2-(thiophen-2-yl)acetic acid

C20H29NO3S (363.1868044)


   

N-((2,2-Dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine

{[3-(cyclopent-1-en-1-yl)phenyl]methyl}({2-[(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]ethyl})amine

C24H29NO2 (363.2198174)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists

   
   
   
   

antofine

InChI=1/C23H25NO3/c1-25-15-6-7-16-18(10-15)20-12-23(27-3)22(26-2)11-19(20)17-9-14-5-4-8-24(14)13-21(16)17/h6-7,10-12,14H,4-5,8-9,13H2,1-3H3/t14-/m1/s

C23H25NO3 (363.18343400000003)


(-)-antofine is an organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities. It has a role as an antineoplastic agent, a plant metabolite, a phytotoxin, an antimicrobial agent, an anti-inflammatory agent, an antiviral agent and an angiogenesis inhibitor. It is an organic heteropentacyclic compound, an aromatic ether, an alkaloid and an alkaloid antibiotic. (13aR)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine is a natural product found in Ficus septica, Vincetoxicum paniculatum, and other organisms with data available. An organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities.

   
   
   
   
   
   
   
   
   
   

Dechlorodauricumine

Dechlorodauricumine

C19H25NO6 (363.168179)


   

Opipramol

Opipramol

C23H29N3O (363.2310504)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   
   

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indole-3-carboxamide

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indole-3-carboxamide

C22H25N3O2 (363.194667)


   
   
   
   
   

1,3-dihydroxy-2,4-bis(3-methylbut-2-enyl)-9a,10-dihydro-4aH-acridin-9-one|1,3-dihydroxy-2,4-diprenylacridone|atalaphylline

1,3-dihydroxy-2,4-bis(3-methylbut-2-enyl)-9a,10-dihydro-4aH-acridin-9-one|1,3-dihydroxy-2,4-diprenylacridone|atalaphylline

C23H25NO3 (363.18343400000003)


   
   
   
   

2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4-methoxyquinoline

2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4-methoxyquinoline

C23H25NO3 (363.18343400000003)


   

2alpha-hydroxylenticellarine

2alpha-hydroxylenticellarine

C19H25NO6 (363.168179)


   

(15E)-12beta-acetoxy-18-nor-senecionane-11,16-dione|Crotastriatin|crotastriatine|O-acetyl-nilgirine

(15E)-12beta-acetoxy-18-nor-senecionane-11,16-dione|Crotastriatin|crotastriatine|O-acetyl-nilgirine

C19H25NO6 (363.168179)


   
   
   

3,7-dimethoxy-6-hydroxy-11,12,13,14,14a,15-hexahydro-9H-phenanthro[9,10-b]quinolizidine|Boehmeriasin B

3,7-dimethoxy-6-hydroxy-11,12,13,14,14a,15-hexahydro-9H-phenanthro[9,10-b]quinolizidine|Boehmeriasin B

C23H25NO3 (363.18343400000003)


   
   
   

(+)-miliusane V|8beta-acetylamino-9beta-hydroxy-1beta-(2,6-dimethylhepta-1,5-dienyl)-2-oxa-spiro[4.5]dec-7-ene-3,6-dione

(+)-miliusane V|8beta-acetylamino-9beta-hydroxy-1beta-(2,6-dimethylhepta-1,5-dienyl)-2-oxa-spiro[4.5]dec-7-ene-3,6-dione

C20H29NO5 (363.20456240000004)


   
   
   

O-Methylhernandine

O-Methylhernandine

C19H25NO6 (363.168179)


   
   
   

(2E)-11-(4-aminophenyl)-5,9-dihydroxy-4,6,8-trimethyl-11-oxo-undec-2-enoic acid

(2E)-11-(4-aminophenyl)-5,9-dihydroxy-4,6,8-trimethyl-11-oxo-undec-2-enoic acid

C20H29NO5 (363.20456240000004)


   
   

(7E,9aS,11S,13S,13aS)-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-11-methyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|lycoposerramine-T

(7E,9aS,11S,13S,13aS)-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-11-methyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|lycoposerramine-T

C20H29NO5 (363.20456240000004)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

3,N4-4-Oxo-(2E)-nonenal-deoxycytidine

3,N4-4-Oxo-(2E)-nonenal-deoxycytidine

C18H25N3O5 (363.179412)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Isopentenyladenine-9-N-glucoside

Isopentenyladenine-9-N-glucoside

C17H25N5O4 (363.190645)


   
   

Talinolol

N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N-cyclohexylcarbamimidic acid

C20H33N3O3 (363.2521788)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

NAT 16:0

N-hexadecanoyl-taurine

C18H37NO4S (363.24431620000007)


   

1-N-Boc-4-(2-Ncbzaminoethyl)piperazine

1-N-Boc-4-(2-Ncbzaminoethyl)piperazine

C19H29N3O4 (363.21579540000005)


   

Ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8 ]naphthyridine-3-carboxylate

Ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8 ]naphthyridine-3-carboxylate

C22H25N3O2 (363.194667)


   

dimethyl-bis(prop-2-enyl)azanium,2-hydroxypropyl prop-2-enoate,prop-2-enoic acid,chloride

dimethyl-bis(prop-2-enyl)azanium,2-hydroxypropyl prop-2-enoate,prop-2-enoic acid,chloride

C17H30ClNO5 (363.18124000000006)


   

6-(4-(4-CYANOPHENYL)PHENOXY)HEXYL METHA&

6-(4-(4-CYANOPHENYL)PHENOXY)HEXYL METHA&

C23H25NO3 (363.18343400000003)


   

3-HYDROXY-2,3-DIMETHYLBUTAN-2-YL HYDROGEN (3-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)PHENYL)BORONATE

3-HYDROXY-2,3-DIMETHYLBUTAN-2-YL HYDROGEN (3-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)PHENYL)BORONATE

C21H22BNO4 (363.16418020000003)


   

(2-PHTALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER

(2-PHTALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER

C21H22BNO4 (363.16418020000003)


   

2-dihexoxyphosphoryl-N,N-diethylacetamide

2-dihexoxyphosphoryl-N,N-diethylacetamide

C18H38NO4P (363.25383180000006)


   
   

(4-PHTHALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER

(4-PHTHALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER

C21H22BNO4 (363.16418020000003)


   
   

1-CBZ-4-(2-N-BOC-AMINO-ETHYL)-PIPERAZINE

1-CBZ-4-(2-N-BOC-AMINO-ETHYL)-PIPERAZINE

C19H29N3O4 (363.21579540000005)


   

1-(1-butylpiperidin-4-yl)-2-methyl-2-phenyl-3H-inden-1-ol

1-(1-butylpiperidin-4-yl)-2-methyl-2-phenyl-3H-inden-1-ol

C25H33NO (363.25620080000004)


   

1-Benzyl-4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]piperidine

1-Benzyl-4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]piperidine

C24H29NO2 (363.2198174)


   

3-{5-[(2R)-2-Aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propy l benzoate

3-{5-[(2R)-2-Aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propy l benzoate

C22H25N3O2 (363.194667)


   

erythro-N-[(Phenylmethoxy)carbonyl]-3-allyl-L-aspartic acid 1-tert-butyl ester

erythro-N-[(Phenylmethoxy)carbonyl]-3-allyl-L-aspartic acid 1-tert-butyl ester

C19H25NO6 (363.168179)


   

1-(2-CHLORO-PHENYL)-PROP-2-YN-1-OL

1-(2-CHLORO-PHENYL)-PROP-2-YN-1-OL

C20H21N5O2 (363.1695166)


   
   

Pirolazamide

Pirolazamide

C23H29N3O (363.2310504)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

(R)-TERT-BUTYL 4-(4-(BENZYLOXY)BUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

(R)-TERT-BUTYL 4-(4-(BENZYLOXY)BUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

C21H33NO4 (363.2409458000001)


   

((1R,2R)-2-AMINO-CYCLOHEXYL)-METHANOL

((1R,2R)-2-AMINO-CYCLOHEXYL)-METHANOL

C20H27F2N3O (363.21220760000006)


   

Libenzapril

Libenzapril

C18H25N3O5 (363.179412)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

4-Boc-7-Bocamino-3,4-dihydroquinoxalin-2-one

4-Boc-7-Bocamino-3,4-dihydroquinoxalin-2-one

C18H25N3O5 (363.179412)


   

4-ethenoxybutyl N-(3-triethoxysilylpropyl)carbamate

4-ethenoxybutyl N-(3-triethoxysilylpropyl)carbamate

C16H33NO6Si (363.2077038)


   

1-Morpholino-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol

1-Morpholino-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol

C19H30BNO5 (363.221692)


   

7-Amino-6-phenoxy-3-[(tetrahydrofuran-2-yl)methyl]quinazolin-4(3H)-one

7-Amino-6-phenoxy-3-[(tetrahydrofuran-2-yl)methyl]quinazolin-4(3H)-one

C22H25N3O2 (363.194667)


   

Isopropyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate

Isopropyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate

C19H29N3O4 (363.21579540000005)


   

tert-butyl 3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}azetidine-1-carboxylate

tert-butyl 3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}azetidine-1-carboxylate

C18H30BN3O4 (363.232925)


   

(15E)-12β-Acetoxy-18-norsenecionan-11,16-dione

(15E)-12β-Acetoxy-18-norsenecionan-11,16-dione

C19H25NO6 (363.168179)


   

2-(((tert-Butyldimethylsilyl)oxy)methyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

2-(((tert-Butyldimethylsilyl)oxy)methyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

C19H34BNO3Si (363.24008840000005)


   

4-(tert-Butyldiphenylsilyloxy)cyclohexanecarbonitrile

4-(tert-Butyldiphenylsilyloxy)cyclohexanecarbonitrile

C23H29NOSi (363.2018304)


   

5-(2-Aminopropyl)-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile

5-(2-Aminopropyl)-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile

C22H25N3O2 (363.194667)


   

4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE

4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE

C19H30BNO5 (363.221692)


   

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine

C18H26BNO4S (363.1675506000001)


   

1-Bromo(20,20,20-2H3)icosane

1-Bromo(20,20,20-2H3)icosane

C20H38BrD3 (363.257976134)


   

1-Benzyl-4-(5,6-dimethoxy-1H-2-indenylmethyl)piperidine

1-Benzyl-4-(5,6-dimethoxy-1H-2-indenylmethyl)piperidine

C24H29NO2 (363.2198174)


   
   

N-((1-(5-Fluoropentyl)-1H-indazol-3-yl)carbonyl)valine methyl ester

N-((1-(5-Fluoropentyl)-1H-indazol-3-yl)carbonyl)valine methyl ester

C19H26FN3O3 (363.1958098)


   

Dioncophylline B

Dioncophylline B

C23H25NO3 (363.18343400000003)


A natural product found in Triphyophyllum peltatum.

   

D-Galactitol, 2-(acetylmethylamino)-2-deoxy-3,4,6-tri-O-methyl-, 1,5-diacetate

D-Galactitol, 2-(acetylmethylamino)-2-deoxy-3,4,6-tri-O-methyl-, 1,5-diacetate

C16H29NO8 (363.1893074)


   

19-(Cyclopropylamino)-4,6,7,15-Tetrahydro-5h-16,1-(Azenometheno)-10,14-(Metheno)pyrazolo[4,3-O][1,3,9]triazacyclohexadecin-8(9h)-One

19-(Cyclopropylamino)-4,6,7,15-Tetrahydro-5h-16,1-(Azenometheno)-10,14-(Metheno)pyrazolo[4,3-O][1,3,9]triazacyclohexadecin-8(9h)-One

C19H21N7O (363.1807496)


   

Cetrimonium Bromide

Hexadecyl trimethyl ammonium bromide

C19H42BrN (363.25004320000005)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent C254 - Anti-Infective Agent > C52588 - Antibacterial Agent D000890 - Anti-Infective Agents

   

5-[6-(Cyclohexylamino)-9-purinyl]-2-(hydroxymethyl)-4-methoxy-3-oxolanol

5-[6-(Cyclohexylamino)-9-purinyl]-2-(hydroxymethyl)-4-methoxy-3-oxolanol

C17H25N5O4 (363.190645)


   

2-[4-(2-methylpropyl)phenyl]propanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester

2-[4-(2-methylpropyl)phenyl]propanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester

C23H25NO3 (363.18343400000003)


   

N-ethyl-N-(2-ethylphenyl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

N-ethyl-N-(2-ethylphenyl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

C22H25N3O2 (363.194667)


   

N-[1-(2,3-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2,5-dimethyl-3-pyrazolecarboxamide

N-[1-(2,3-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2,5-dimethyl-3-pyrazolecarboxamide

C21H25N5O (363.2059)


   

N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2,5-dimethyl-3-pyrazolecarboxamide

N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2,5-dimethyl-3-pyrazolecarboxamide

C21H25N5O (363.2059)


   

1-(4-Fluorophenyl)-1-cyclopentanecarboxylic acid [2-(2,6-dimethyl-4-morpholinyl)-2-oxoethyl] ester

1-(4-Fluorophenyl)-1-cyclopentanecarboxylic acid [2-(2,6-dimethyl-4-morpholinyl)-2-oxoethyl] ester

C20H26FNO4 (363.18457680000006)


   

6-fluoro-2-phenyl-N-(3-(piperidin-1-yl)propyl)quinolin-4-amine

6-fluoro-2-phenyl-N-(3-(piperidin-1-yl)propyl)quinolin-4-amine

C23H26FN3 (363.21106480000003)


   

5-[(3-Phenylmethoxy-1-piperidinyl)methyl]-3-(phenylmethyl)-1,2,4-oxadiazole

5-[(3-Phenylmethoxy-1-piperidinyl)methyl]-3-(phenylmethyl)-1,2,4-oxadiazole

C22H25N3O2 (363.194667)


   

1-(1,3-benzoxazol-2-yl)-N-[(4-ethylphenyl)methyl]-3-piperidinecarboxamide

1-(1,3-benzoxazol-2-yl)-N-[(4-ethylphenyl)methyl]-3-piperidinecarboxamide

C22H25N3O2 (363.194667)


   

(5Z)-4-methoxy-3-methyl-5-[(1R,9R,10R,11R,12S)-12-methyl-5-oxido-14,15-dioxa-5-azoniatetracyclo[7.5.1.01,11.05,10]pentadecan-13-ylidene]furan-2-one

(5Z)-4-methoxy-3-methyl-5-[(1R,9R,10R,11R,12S)-12-methyl-5-oxido-14,15-dioxa-5-azoniatetracyclo[7.5.1.01,11.05,10]pentadecan-13-ylidene]furan-2-one

C19H25NO6 (363.168179)


   

3-methyl-2-[[2-(methylamino)-1-oxopropyl]amino]-N-[1-oxo-1-(phenylhydrazo)propan-2-yl]butanamide

3-methyl-2-[[2-(methylamino)-1-oxopropyl]amino]-N-[1-oxo-1-(phenylhydrazo)propan-2-yl]butanamide

C18H29N5O3 (363.2270284)


   

1-Tetradecanoyl-sn-glycero-2,3-cyclic phosphate

1-Tetradecanoyl-sn-glycero-2,3-cyclic phosphate

C17H32O6P- (363.19364020000006)


   
   
   

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.179412)


   

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.21579540000005)


   

3-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-N-(3,4-dihydro-2H-pyrrol-5-yl)benzamide

3-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-N-(3,4-dihydro-2H-pyrrol-5-yl)benzamide

C19H21N7O (363.1807496)


   

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-(2-morpholin-4-yl-2-oxoethyl)oxan-3-yl]pyridine-2-carboxamide

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-(2-morpholin-4-yl-2-oxoethyl)oxan-3-yl]pyridine-2-carboxamide

C18H25N3O5 (363.179412)


   

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.179412)


   

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.21579540000005)


   

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.21579540000005)


   

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.21579540000005)


   

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.21579540000005)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.179412)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.21579540000005)


   

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.21579540000005)


   

4-oxanyl-[(1R,5S)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone

4-oxanyl-[(1R,5S)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone

C22H25N3O2 (363.194667)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.21579540000005)


   

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.179412)


   

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.179412)


   

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.179412)


   

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.179412)


   

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.21579540000005)


   

(1S,5R)-N-(3-methoxyphenyl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1S,5R)-N-(3-methoxyphenyl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C22H25N3O2 (363.194667)


   

(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoic acid

(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoic acid

C19H29N3O4 (363.21579540000005)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

1H-5alpha-Androst-2-eno[3,2-b]indol-17beta-ol

1H-5alpha-Androst-2-eno[3,2-b]indol-17beta-ol

C25H33NO (363.25620080000004)


   

L-arginyl-L-glutamic acid monoacetate

L-arginyl-L-glutamic acid monoacetate

C13H25N5O7 (363.17539)


   

(2R,3S,4S,5R,6S)-2-ethyl-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol

(2R,3S,4S,5R,6S)-2-ethyl-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol

C17H25N5O4 (363.190645)


   

Heptanone-etheno dC

Heptanone-etheno dC

C18H25N3O5 (363.179412)


   
   

N-Acetylalanylphenylalanylalanine methyl ester

N-Acetylalanylphenylalanylalanine methyl ester

C18H25N3O5 (363.179412)


   

(2S)-2-[4-(1-Ethoxyethoxy)-1-oxobutyl]pyrrolidine-1-carboxylic acid benzyl ester

(2S)-2-[4-(1-Ethoxyethoxy)-1-oxobutyl]pyrrolidine-1-carboxylic acid benzyl ester

C20H29NO5 (363.20456240000004)


   

6-Methoxy-9-[2-(6-methylpyridin-3-yl)ethyl]-3-propyl-1,2,3,4-tetrahydro-gamma-carboline

6-Methoxy-9-[2-(6-methylpyridin-3-yl)ethyl]-3-propyl-1,2,3,4-tetrahydro-gamma-carboline

C23H29N3O (363.2310504)


   

[2-[Acetyl(methyl)amino]-5-acetyloxy-1-deuterio-3,4,6-trimethoxyhexyl] acetate

[2-[Acetyl(methyl)amino]-5-acetyloxy-1-deuterio-3,4,6-trimethoxyhexyl] acetate

C16H29NO8 (363.1893074)


   

N-Hexadecanoyltaurine

N-Hexadecanoyltaurine

C18H37NO4S (363.24431620000007)


A fatty acid-taurine conjugate derived from hexadecanoic acid.

   

stemocurtisine N-oxide

stemocurtisine N-oxide

C19H25NO6 (363.168179)


A natural product found in Stemona curtisii.

   

SPHP(18:1)

SPHP(m18:1)

C18H38NO4P (363.25383180000006)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate

Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate

C19H26FN3O3 (363.1958098)


   
   
   
   
   
   
   
   

ZINC13466751

ZINC13466751

C20H21N5O2 (363.1695166)


ZINC13466751 is a potent inhibitor of HIF-1α/von Hippel-Lindau interaction with an IC50 of 2.0 μM[1].